Edwards Lifesciences Corporation
New York Stock Exchange•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Company Description
- CEO
- Mr. Bernard J. Zovighian
- Full Time Employees
- 19,800
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- One Edwards Way Irvine CA United States of America 92614
- IPO Date
- Mar 27, 2000
- CIK
- 0001099800
- Website
- edwards.com
- Similar Companies
- Business
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Company News
Shareholder Rights Advocates at Levi & Korsinsky Investigate Edwards Lifesciences Corporation (EW) Regarding Possible Securities Fraud Violations
Edwards Lifesciences Corporation (EW) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
Edwards Lifesciences Soars on TTVR Approval, But Challenges Remain
ATTENTION EW SHAREHOLDERS: Investors who lost money on Edwards Lifesciences Corporation are urged to contact Levi & Korsinsky about an ongoing investigation
TFX vs. EW: Which Stock Is the Better Value Option?
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Edwards Lifesciences Corporation (EW)
Is it the Right Time to Hold EW Stock in Your Portfolio Now?
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Edwards Lifesciences Corporation (EW)
EW ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Edwards Lifesciences Corporation
Edwards Lifesciences Corporation Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - EW
Edwards Lifesciences Corporation Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - EW
ONE-YEAR DATA SHOW EXCELLENT OUTCOMES FOR ENDOTRONIX CORDELLA PULMONARY ARTERY SENSOR SYSTEM
Shareholder Rights Advocates at Levi & Korsinsky Investigate Edwards Lifesciences Corporation (EW) Regarding Possible Securities Fraud Violations
Investors who lost money on Edwards Lifesciences Corporation should contact Levi & Korsinsky about an ongoing investigation - EW
ATTENTION EW SHAREHOLDERS: Investors who Lost Money on Edwards Lifesciences Corporation are Urged to Contact Levi & Korsinsky About an Ongoing Investigation
What's Happening With Edwards Lifesciences Stock?
Levi & Korsinsky Announces an Investigation on Behalf of Edwards Lifesciences Corporation (EW) Shareholders Who May Have Been Affected by Fraud
Edwards Lifesciences Corporation INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Edwards Lifesciences (EW)
TFX vs. EW: Which Stock Should Value Investors Buy Now?
EW STOCK ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of an Ongoing Investigation